未登录

J

Jennifer Y. Xie

arkansas state university

H指数:29

被引数:3,060

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

CAP1 (cyclase-associated protein 1) mediates the cyclic AMP signals that activate Rap1 in stimulating matrix adhesion of colon cancer cells

CELLULAR SIGNALLING

IF3.7

2023-04-015

OA

Dynamic Phosphorylation and Dephosphorylation of Cyclase-Associated Protein 1 by Antagonistic Signaling through Cyclin-Dependent Kinase 5 and cAMP Are Critical for the Protein Functions in Actin Filament Disassembly and Cell Adhesion

MOLECULAR AND CELLULAR BIOLOGY

IF2.7

2023-03-0310

OA

Gold Nanorod Substrate for Rat Fetal Neural Stem Cell Differentiation into Oligodendrocytes

IF4.3

2022-03-115

OAAI

Functionalized Nanocellulose Drives Neural Stem Cells toward Neuronal Differentiation

JOURNAL OF FUNCTIONAL BIOMATERIALS

IF5.2

2021-11-226

OAAI

TEMPO Cellulose Supports Survival and in vitro Differentiation of Rat Neural Stem Cell

IF4.2

2021-05-140

PRE

Chronicling changes in the somatosensory neurons after peripheral nerve injury

周围神经损伤后体感神经元的慢性变化

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

IF9.1

2020-10-055

OAAI

Dynamic Phosphorylation and Dephosphorylation of CAP1 (Cyclase-Associated Protein 1) by Antagonistic Signaling through CDK5 and cAMP are Critical for the Protein Functions in Actin Filament Disassembly and Cell Adhesion

IF4.2

2020-04-160

OA

The prolactin receptor long isoform regulates nociceptor sensitization and opioid-induced hyperalgesia selectively in females

SCIENCE TRANSLATIONAL MEDICINE

IF14.6

2020-02-0552

OAAI

Antihyperalgesic effects of Meteorin in the rat chronic constriction injury model: a replication study

IF5.5

2019-03-2111

OAAI

Design and Synthesis of a Novel and Selective Kappa Opioid Receptor (KOR) Antagonist (BTRX-335140)

JOURNAL OF MEDICINAL CHEMISTRY

IF6.8

2019-02-0141

OAAI

Positive allosteric modulators of nonbenzodiazepine γ-aminobutyric acidA receptor subtypes for the treatment of chronic pain

IF5.5

2018-09-0714

OAAI

Selective deficiencies in descending inhibitory modulation in neuropathic rats: implications for enhancing noradrenergic tone

IF5.5

2018-05-3120

OAAI

Multiple sites and actions of gabapentin-induced relief of ongoing experimental neuropathic pain

加巴喷丁诱导的正在进行的实验性神经性疼痛缓解的多部位和作用

IF5.5

2017-08-2181

OAAI

CRISPR/Cas9 editing of Nf1 gene identifies CRMP2 as a therapeutic target in neurofibromatosis type 1-related pain that is reversed by (S)-Lacosamide

IF5.5

2017-07-0365

OAAI

Kappa opioid receptor antagonists: A possible new class of therapeutics for migraine prevention

IF4.6

2017-04-0480

OAAI

Anatomy and immunochemical characterization of the non-arterial peptidergic diffuse dural innervation of the rat and Rhesus monkey: Implications for functional regulation and treatment in migraine

IF4.6

2016-11-1627

PREAI

Discovery of Stable Non-opioid Dynorphin A Analogues Interacting at the Bradykinin Receptors for the Treatment of Neuropathic Pain

ACS CHEMICAL NEUROSCIENCE

IF3.9

2016-09-278

OAAI

Sustained relief of ongoing experimental neuropathic pain by a CRMP2 peptide aptamer with low abuse potential

IF5.5

2016-05-2831

OAAI

Prevention of stress- or nitric oxide donor-induced medication overuse headache by a calcitonin gene-related peptide antibody in rodents

IF4.6

2016-05-1960

PREAI

(S)-lacosamide inhibition of CRMP2 phosphorylation reduces postoperative and neuropathic pain behaviors through distinct classes of sensory neurons identified by constellation pharmacology

IF5.5

2016-03-0952

OA